-
Oklo is working on cutting-edge nuclear energy solutions called Small Modular Reactors (SMRs).
-
While Oklo’s stock saw significant gains in 2025, the company is still in the process of obtaining the regulatory approvals necessary to commence operations.
-
For investors who prefer lower risk, exploring nuclear ETFs might be a wise choice.
As enthusiasm around growth stocks rises, many might assume that this upward trend is sustainable. Yet, history tells us otherwise.
Currently, Oklo (NYSE: OKLO) is experiencing a decline for some unknown reason. As of 12:10 PM ET, shares have dropped by 4%, adding to an earlier decrease of 6.5%.
In 2025, plenty of excitement surrounded Oklo’s stock. Political backing for advanced nuclear reactors was on the increase. However, much of the stock’s surge this year is based on potential rather than tangible benefits.
Unlike its competitor, Nuscale (NYSE: SMR), Oklo has yet to gain approval for its SMR design from the U.S. Nuclear Regulatory Commission, making its path to commercial launch more uncertain than that of its peers.
While bullish investors are optimistic about Oklo’s future, some believe that the stock might be overvalued. Seaport Research downgraded it to neutral just yesterday, citing high valuation as the concern. It seems that everyday investors might find Seaport’s assessment to be a more rational perspective compared to those who are still buying into the stock.
As for Oklo stock today, I’ve been watching from home, and it looks like some folks are stepping in, but that doesn’t imply it’s time to buy. There are significant obstacles that must be surmounted before any revenue generation can commence.
For cautious investors interested in nuclear energy, it’s worth considering alternatives to Oklo or even Nuscale, each of which carries its own risks. Nuclear energy ETFs could be a reasonable option for those seeking safer investments.
It’s important to reflect a bit before deciding to invest in Oklo.
The Motley Fool’s analyst team suggests a list of stocks they believe are worth buying now, and surprisingly, Oklo isn’t included. The listed stocks could potentially yield substantial returns in the coming years.
